Cargando…

Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important

BACKGROUND: Despite multiple available HIV prevention methods, the HIV epidemic continues to affect South Africa the most. We sought to understand willingness to use actual and hypothetical HIV prevention methods among participants enrolled in a preventative HIV vaccine efficacy trial in Soweto, Sou...

Descripción completa

Detalles Bibliográficos
Autores principales: Laher, Fatima, Salami, Taibat, Hornschuh, Stefanie, Makhale, Lerato M., Khunwane, Mamakiri, Andrasik, Michele P., Gray, Glenda E., Van Tieu, Hong, Dietrich, Janan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648553/
https://www.ncbi.nlm.nih.gov/pubmed/33160341
http://dx.doi.org/10.1186/s12889-020-09785-0
_version_ 1783607136507396096
author Laher, Fatima
Salami, Taibat
Hornschuh, Stefanie
Makhale, Lerato M.
Khunwane, Mamakiri
Andrasik, Michele P.
Gray, Glenda E.
Van Tieu, Hong
Dietrich, Janan J.
author_facet Laher, Fatima
Salami, Taibat
Hornschuh, Stefanie
Makhale, Lerato M.
Khunwane, Mamakiri
Andrasik, Michele P.
Gray, Glenda E.
Van Tieu, Hong
Dietrich, Janan J.
author_sort Laher, Fatima
collection PubMed
description BACKGROUND: Despite multiple available HIV prevention methods, the HIV epidemic continues to affect South Africa the most. We sought to understand willingness to use actual and hypothetical HIV prevention methods among participants enrolled in a preventative HIV vaccine efficacy trial in Soweto, South Africa. METHODS: We conducted a qualitative study with 38 self-reporting HIV-uninfected and consenting 18–35 year olds participating in the HVTN 702 vaccine efficacy trial in Soweto. Using a semi-structured interview guide, five focus group discussions (FGDs) were held, stratified by age, gender and sexual orientation. The FGDs were composed of: (i) 10 heterosexual women aged 18–24 years; (ii) 9 heterosexual and bisexual women aged 25–35 years; (iii & iv) heterosexual men aged 25–35 years with 7 in both groups; and (v) 5 men aged 18–35 years who have sex with men. FGDs were audio-recorded, transcribed verbatim, translated into English and analysed using thematic analysis. RESULTS: We present five main themes: (i) long-lasting methods are preferable; (ii) condoms are well-known but not preferred for use; (iii) administration route of HIV prevention method is a consideration for the user; (iv) ideal HIV prevention methods should blend into the lifestyle of the user; and the perception that (v) visible prevention methods indicate sexual indiscretion. CONCLUSIONS: The participants’ candour about barriers to condom and daily oral pre-exposure prophylaxis (PrEP) use, and expressed preferences for long-lasting, discreet, lifestyle-friendly methods reveal a gap in the biomedical prevention market aiming to reduce sexually acquired HIV in South Africa. Product developers should consider long-acting injectable formulations, such as vaccines, passive antibodies and chemoprophylaxis, for HIV prevention technologies. Future innovations in HIV prevention products may need to address the desire for the method to blend easily into lifestyles, such as food-medication formulations.
format Online
Article
Text
id pubmed-7648553
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76485532020-11-09 Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important Laher, Fatima Salami, Taibat Hornschuh, Stefanie Makhale, Lerato M. Khunwane, Mamakiri Andrasik, Michele P. Gray, Glenda E. Van Tieu, Hong Dietrich, Janan J. BMC Public Health Research Article BACKGROUND: Despite multiple available HIV prevention methods, the HIV epidemic continues to affect South Africa the most. We sought to understand willingness to use actual and hypothetical HIV prevention methods among participants enrolled in a preventative HIV vaccine efficacy trial in Soweto, South Africa. METHODS: We conducted a qualitative study with 38 self-reporting HIV-uninfected and consenting 18–35 year olds participating in the HVTN 702 vaccine efficacy trial in Soweto. Using a semi-structured interview guide, five focus group discussions (FGDs) were held, stratified by age, gender and sexual orientation. The FGDs were composed of: (i) 10 heterosexual women aged 18–24 years; (ii) 9 heterosexual and bisexual women aged 25–35 years; (iii & iv) heterosexual men aged 25–35 years with 7 in both groups; and (v) 5 men aged 18–35 years who have sex with men. FGDs were audio-recorded, transcribed verbatim, translated into English and analysed using thematic analysis. RESULTS: We present five main themes: (i) long-lasting methods are preferable; (ii) condoms are well-known but not preferred for use; (iii) administration route of HIV prevention method is a consideration for the user; (iv) ideal HIV prevention methods should blend into the lifestyle of the user; and the perception that (v) visible prevention methods indicate sexual indiscretion. CONCLUSIONS: The participants’ candour about barriers to condom and daily oral pre-exposure prophylaxis (PrEP) use, and expressed preferences for long-lasting, discreet, lifestyle-friendly methods reveal a gap in the biomedical prevention market aiming to reduce sexually acquired HIV in South Africa. Product developers should consider long-acting injectable formulations, such as vaccines, passive antibodies and chemoprophylaxis, for HIV prevention technologies. Future innovations in HIV prevention products may need to address the desire for the method to blend easily into lifestyles, such as food-medication formulations. BioMed Central 2020-11-07 /pmc/articles/PMC7648553/ /pubmed/33160341 http://dx.doi.org/10.1186/s12889-020-09785-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Laher, Fatima
Salami, Taibat
Hornschuh, Stefanie
Makhale, Lerato M.
Khunwane, Mamakiri
Andrasik, Michele P.
Gray, Glenda E.
Van Tieu, Hong
Dietrich, Janan J.
Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
title Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
title_full Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
title_fullStr Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
title_full_unstemmed Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
title_short Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
title_sort willingness to use hiv prevention methods among vaccine efficacy trial participants in soweto, south africa: discretion is important
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648553/
https://www.ncbi.nlm.nih.gov/pubmed/33160341
http://dx.doi.org/10.1186/s12889-020-09785-0
work_keys_str_mv AT laherfatima willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT salamitaibat willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT hornschuhstefanie willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT makhaleleratom willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT khunwanemamakiri willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT andrasikmichelep willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT grayglendae willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT vantieuhong willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant
AT dietrichjananj willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant